These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16462936)

  • 41. The role of statin therapy in preventing recurrent stroke.
    Turner AM; Jowett NI
    Nurs Times; 2006 Sep 19-25; 102(38):25-6. PubMed ID: 17017577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic predisposition to statin myopathy.
    Vladutiu GD
    Curr Opin Rheumatol; 2008 Nov; 20(6):648-55. PubMed ID: 18946323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The genetic determinants of atorvastatin response.
    Rodrigues AC; Hirata MH; Hirata RD
    Curr Opin Mol Ther; 2007 Dec; 9(6):545-53. PubMed ID: 18041665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fatal and widespread skeletal myopathy confirmed morphologically years after initiation of simvastatin therapy.
    Boltan DD; Lachar W; Khetan A; Bouffard JP; Roberts WC
    Am J Cardiol; 2007 Apr; 99(8):1171-6. PubMed ID: 17437752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study.
    Sailler L; Pereira C; Bagheri A; Uro-Coste E; Roussel B; Adoue D; Fournie B; Laroche M; Zabraniecki L; Cintas P; Arlet P; Lapeyre-Mestre M; Montastruc JL
    Ann Rheum Dis; 2008 May; 67(5):614-9. PubMed ID: 17768174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study.
    Goettsch WG; Heintjes EM; Kastelein JJ; Rabelink TJ; Johansson S; Herings RM
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):435-43. PubMed ID: 16761304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Statins and neuromuscular pathology].
    Turpin-Fenoll L; Millan-Pascual J; Martin-Estefania C
    Rev Neurol; 2008 Jul 1-15; 47(1):46-51. PubMed ID: 18592480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid-lowering therapy--benefits and risks.
    Shechter M
    Isr Med Assoc J; 2007 Feb; 9(2):133; author reply 133-4. PubMed ID: 17348492
    [No Abstract]   [Full Text] [Related]  

  • 49. Statins and cancer risk: decrease or increase?
    Goldstein MR; Mascitelli L; Pezzetta F
    Am J Med; 2008 Sep; 121(9):e17, author reply e19. PubMed ID: 18724946
    [No Abstract]   [Full Text] [Related]  

  • 50. Who should receive a statin these days? Lessons from recent clinical trials.
    Shepherd J
    J Intern Med; 2006 Oct; 260(4):305-19. PubMed ID: 16961668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid-lowering therapy--benefits and risks.
    Abinader EG
    Isr Med Assoc J; 2007 Feb; 9(2):132-3; author reply 133-4. PubMed ID: 17354321
    [No Abstract]   [Full Text] [Related]  

  • 52. Comment on "Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data".
    Kuss O; Rathmann W
    Drug Saf; 2023 May; 46(5):509-512. PubMed ID: 37060425
    [No Abstract]   [Full Text] [Related]  

  • 53. A missed protective drug-drug interaction of DPP-4 inhibitors and statins on myopathy risk.
    Kuss O; Rathmann W
    Acta Diabetol; 2020 Jan; 57(1):113-114. PubMed ID: 31691868
    [No Abstract]   [Full Text] [Related]  

  • 54. Statins linked to muscle injuries.
    Harv Mens Health Watch; 2013 Sep; 18(2):8. PubMed ID: 27024727
    [No Abstract]   [Full Text] [Related]  

  • 55. Venous thromboembolism, statins and the protein unfolding response.
    Michie CA; Rosen SD; Guirguis R
    Int J Clin Pract; 2011 Apr; 65(4):376-7. PubMed ID: 21401823
    [No Abstract]   [Full Text] [Related]  

  • 56. The patient's page.
    South Med J; 2005 May; 98(5):585. PubMed ID: 15954526
    [No Abstract]   [Full Text] [Related]  

  • 57. Alcohol-induced myopathy: what is the role of mitochondria?
    Krähenbühl S
    Hepatology; 2001 Jul; 34(1):210-1. PubMed ID: 11431754
    [No Abstract]   [Full Text] [Related]  

  • 58. High-Dose Statins in Preventing Microvascular Obstruction: "The Devil Lies in the Details".
    Laborante R; Bianchini E; Borovac JA; D'Amario D
    Am J Cardiol; 2023 Nov; 206():384-387. PubMed ID: 37748957
    [No Abstract]   [Full Text] [Related]  

  • 59. Signal of potentially protective drug-drug interactions from spontaneous reporting systems: proceed with caution.
    Antonazzo IC; Poluzzi E; Forcesi E; Salvo F; Pariente A; Marchesini G; De Ponti F; Raschi E
    Acta Diabetol; 2020 Jan; 57(1):115-116. PubMed ID: 31691870
    [No Abstract]   [Full Text] [Related]  

  • 60. Statins and BCG response: Is there more to the story?
    Myers AA; Kamat AM
    Scott Med J; 2024 Feb; 69(1):1-2. PubMed ID: 38557231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.